B

Biomed Lublin Wytwornia Surowic i Szczepionek SA
WSE:BML

Watchlist Manager
Biomed Lublin Wytwornia Surowic i Szczepionek SA
WSE:BML
Watchlist
Price: 5.8 PLN 1.67% Market Closed
Market Cap: zł378.5m

Operating Margin

22%
Current
Improving
by 1.2%
vs 3-y average of 20.8%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
22%
=
Operating Income
zł11.8m
/
Revenue
zł53.8m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
22%
=
Operating Income
zł11.8m
/
Revenue
zł53.8m

Peer Comparison

Country Company Market Cap Operating
Margin
PL
Biomed Lublin Wytwornia Surowic i Szczepionek SA
WSE:BML
407.5m PLN
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
387.5B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
185.5B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
168.8B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.3B USD
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
NL
argenx SE
XBRU:ARGX
43.2B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.2B USD
Loading...

Market Distribution

Higher than 83% of companies in Poland
Percentile
83rd
Based on 835 companies
83rd percentile
22%
Low
-10 083 900% — -1.5%
Typical Range
-1.5% — 11.7%
High
11.7% — 195 905.3%
Distribution Statistics
Poland
Min -10 083 900%
30th Percentile -1.5%
Median 5.4%
70th Percentile 11.7%
Max 195 905.3%

Biomed Lublin Wytwornia Surowic i Szczepionek SA
Glance View

Market Cap
378.5m PLN
Industry
Biotechnology

Biomed Lublin Wytwornia Surowic i Szczepionek SA engages in the manufacture of pharmaceutical products. The company is headquartered in Lublin, Woj. Lubelskie and currently employs 223 full-time employees. The company went IPO on 2011-07-29.

BML Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
22%
=
Operating Income
zł11.8m
/
Revenue
zł53.8m
What is Biomed Lublin Wytwornia Surowic i Szczepionek SA's current Operating Margin?

The current Operating Margin for Biomed Lublin Wytwornia Surowic i Szczepionek SA is 22%, which is above its 3-year median of 20.8%.

How has Operating Margin changed over time?

Over the last 3 years, Biomed Lublin Wytwornia Surowic i Szczepionek SA’s Operating Margin has increased from 17.6% to 22%. During this period, it reached a low of 8% on Mar 31, 2021 and a high of 22% on May 1, 2023.

Back to Top